Pharma industry spent a record $389M on US lobbying in 2021, but more is likely coming this year — report
Even though pharma lobbyists spent at historic levels in 2021, more records might be broken this year if trends continue, a new report says.
Money and politics watchdog OpenSecrets broke down the flow of money last week in federal and state lobbying efforts from 2021. Upon narrowing down some of the major players and industries involved, the report found that the pharma industry and the health sector itself has been spending a substantial amount of the total.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,700+ biopharma pros reading Endpoints daily — and it's free.